Literature DB >> 2159864

In vitro effect of YTR (tazobactam) on plasmid and chromosomally mediated beta-lactamases.

E E Stobberingh1.   

Abstract

The effect of tazobactam on the piperacillin susceptibility and on the beta-lactamase activity of different strains and species was evaluated. A synergistic effect was observed on the piperacillin susceptibility for all microorganisms tested, irrespective of the type and/or amount of beta-lactamase produced. Addition of gentamicin resulted in a further reduction of the piperacillin MIC. The enzyme activity after induction with piperacillin alone or in combination with tazobactam (4 mg/l) was quite similar.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2159864     DOI: 10.1159/000238768

Source DB:  PubMed          Journal:  Chemotherapy        ISSN: 0009-3157            Impact factor:   2.544


  5 in total

1.  Pharmacokinetics and pharmacodynamics of two multiple-dose piperacillin-tazobactam regimens.

Authors:  D J Occhipinti; S L Pendland; L L Schoonover; E B Rypins; L H Danziger; K A Rodvold
Journal:  Antimicrob Agents Chemother       Date:  1997-11       Impact factor: 5.191

2.  Pharmacodynamics of piperacillin alone and in combination with tazobactam against piperacillin-resistant and -susceptible organisms in an in vitro model of infection.

Authors:  A H Strayer; D H Gilbert; P Pivarnik; A A Medeiros; S H Zinner; M N Dudley
Journal:  Antimicrob Agents Chemother       Date:  1994-10       Impact factor: 5.191

Review 3.  Review of piperacillin/tazobactam in the treatment of bacteremic infections and summary of clinical efficacy.

Authors:  P Charbonneau
Journal:  Intensive Care Med       Date:  1994-07       Impact factor: 17.440

Review 4.  Piperacillin/tazobactam. A review of its antibacterial activity, pharmacokinetic properties and therapeutic potential.

Authors:  H M Bryson; R N Brogden
Journal:  Drugs       Date:  1994-03       Impact factor: 9.546

5.  Piperacillin/Tazobactam (ZOSYN).

Authors:  S M Culver; M G Martens
Journal:  Infect Dis Obstet Gynecol       Date:  1996
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.